Relmada Therapeutics Cash from Operations (TTM) Trends

Relmada Therapeutics Inc (RLMD)

3.72 +0.08 (+2.20%) USD | NASDAQ | May 01, 16:00

3.72 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-51.66M
September 30, 2023	-77.29M
June 30, 2023	-92.52M
March 31, 2023	-100.88M
December 31, 2022	-103.80M
September 30, 2022	-105.58M
June 30, 2022	-99.63M
March 31, 2022	-95.22M
December 31, 2021	-91.87M
September 30, 2021	-61.14M
June 30, 2021	-52.73M
March 31, 2021	-40.47M
December 31, 2020	-27.81M
September 30, 2020	-23.41M
June 30, 2020	-14.58M
March 31, 2020	-11.64M
September 30, 2019	-11.36M
June 30, 2019	-10.50M
March 31, 2019	-9.097M
December 31, 2018	-8.710M

Date	Value
September 30, 2018	-6.694M
June 30, 2018	-6.002M
March 31, 2018	-4.752M
December 31, 2017	-4.982M
September 30, 2017	-5.301M
June 30, 2017	-6.466M
March 31, 2017	-8.276M
December 31, 2016	-10.05M
September 30, 2016	-12.07M
June 30, 2016	-13.14M
March 31, 2016	-14.81M
December 31, 2015	-15.61M
September 30, 2015	-17.12M
June 30, 2015	-16.23M
March 31, 2015	-11.74M
December 31, 2014	-7.318M
September 30, 2014	-2.340M
February 28, 2014	-0.0231M
November 30, 2013	-0.0225M
August 31, 2013	-0.0119M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-105.58M

Minimum

Sep 2022

-10.50M

Maximum

Jun 2019

-59.56M

Average

-56.93M

Median

Cash from Operations (TTM) Benchmarks